Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-08
1999-10-12
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142368, 514256, 514318, 514319, 514320, 514321, 514322, 514324, 514326, 514331, 514397, 514422, 514429, 514325, 544 88, 544130, 544287, 544360, 544405, 546200, 546202, 546203, 546208, 546 22, 546189, 546193, 546198, 548119, 5483121, 5483381, A61K 31445, A61K 3147, A61K 31495, C07D21158, C07D23378, C07D40112, C07D47110
Patent
active
059655771
ABSTRACT:
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof, or prodrug esters thereof,
REFERENCES:
patent: 3754001 (1973-08-01), Timmer et al.
patent: 5712279 (1998-01-01), Biller et al.
patent: 5780465 (1998-07-01), Markley et al.
U.S. Application No. 08/842,132 filed Apr. 23, 1997.
U.S. Application No. 08/847,775, filed Apr. 23, 1997.
Bristol--Myers Squibb Company
Chang Ceila
Rodney Burton
LandOfFree
Heterocyclic inhibitors of microsomal triglyceride transfer prot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic inhibitors of microsomal triglyceride transfer prot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic inhibitors of microsomal triglyceride transfer prot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652828